One-pot hydrothermal synthesis of fluorophore-modified cerium oxide nanoparticles

Cerium oxide nanoparticles (CeO 2 NPs), which have powerful antioxidant properties, are promising nanomaterials for the treatment of diseases associated with oxidative stress. The well-developed surface of CeO 2 NPs makes them promising for use as a multifunctional system for various biomedical appl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physical chemistry chemical physics : PCCP 2024-03, Vol.26 (12), p.9546-9555
Hauptverfasser: Tsyupka, Daria V, Pigarev, Sergey V, Podkolodnaya, Yuliya A, Khudina, Ekaterina A, Popova, Nelli R, Goryacheva, Irina Yu, Goryacheva, Olga A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cerium oxide nanoparticles (CeO 2 NPs), which have powerful antioxidant properties, are promising nanomaterials for the treatment of diseases associated with oxidative stress. The well-developed surface of CeO 2 NPs makes them promising for use as a multifunctional system for various biomedical applications. This work demonstrates a simple approach that allows the direct formation of a molecular fluorophore on the surface of CeO 2 NPs using a simple one-pot hydrothermal synthesis. Thus, we were able to synthesize CeO 2 NPs of ultra-small size ∼2 nm with a narrow distribution, highly stable fluorescence, and a quantum yield of ∼62%. UV-visible transmission studies revealed that the resulting CeO 2 NPs exhibited fast autogenerative catalytic reduction. In vitro results showed high biocompatibility of CeO 2 NPs; their internalization occurs mainly in the region of cell nuclei. Thus, the resulting NPs have the necessary parameters and can be successfully used in biovisualization and therapy. Fluorophore-modified cerium oxide nanoparticles (CeO 2 NPs), which have powerful antioxidant properties and high fluorescence intensity, are promising nanomaterials for the treatment of diseases associated with oxidative stress.
ISSN:1463-9076
1463-9084
DOI:10.1039/d4cp00237g